Abstract16 Introduction: The aim of this study was to investigate whether there is an increased susceptibility to apoptosis in cultured 17 fibroblasts from patients with schizophrenia. 18 Method: Dermal fibroblasts were collected and cultured from three groups: patients with schizophrenia, patients with non-19 schizophrenic psychosis, and healthy comparison subjects. Susceptibility to apoptosis was measured at the level of degradation 20 product (proportion of cells in the sub-G0 cell cycle fraction in which apoptotic bodies accumulate), pro-apoptotic effector 21 (activated caspase-3), and molecular regulators (P53, Bax and Bcl-2). Cell lines were studied under both basal culture and 22 cycloheximide (an apoptotic inducer) exposure conditions. 23 Results: Consistent with increased susceptibility to apoptosis, the proportion of sub-G0 cells under basal conditions was 24 significantly larger in the schizophrenia group, compared to the non-schizophrenic psychosis group. However when apoptosis 25 was stimulated with cycloheximide, the schizophrenia group showed an attenuated caspase-3 response. The pattern of 26 correlations between regulators, caspase-3 and the proportion of sub-G0 cells was different in the schizophrenia group, 27 consistent with group-specific apoptotic pathway dysregulation.0920-9964/$ -see front matter D